PATENT CLAIM ANALYSIS

Application Number: 15893651
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["424", "192100"]

Abstract:
The invention relates to cell stimulatory fusion proteins and DNA sequences, vectors comprising at least two agonists of TNF/TNFR super family, immunoglobulin super family, cytokine family proteins and optional antigen combination. Instructions for use of these proteins and DNA constructs as immune adjuvants and vaccines for treatment of various chronic diseases such as viral infection are also provided. Additionally, the use of these protein and DNA constructs as immune suppressant for treatment of various chronic diseases, such as autoimmunity and organ transplant rejection, is also illustrated.

Claim (Index 6):
The immunostimulatory fusion polypeptide of  claim 1 , which is substantially pure.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 88.0
- Lexical Diversity: 1.66667
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12483876', '15893644', '15893648', '14655752', '11635066']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8203760885180332
- 35 USC 102 Novelty (BERT): 0.7009696340537809
- Combined Prediction Score: 0.808435443071608
- Mean Citation Score: 572.2670999999998
- Max Citation Score: 736.33026
- Similarity Product: 728.9072318966141

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test